Gilead is set to launch a Phase III trial of its once-yearly lenacapavir pre-exposure prophylaxis (PrEP) for human ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Some brand names of emergency contraception ... sexually transmitted infections, including HIV. Plan B One-Step, also called the morning-after pill, is an emergency contraceptive pill that's ...

The combination of tenofovir, FTC, and efavirenz might soon be available in a single pill. For years, effective antiretroviral treatment has required HIV-positive patients to take a large handful ...

A new study by UCSF researchers reveals that long-acting injectable treatments offer a promising alternative for HIV patients who find it challenging to adhere to daily pill regimens. This ...

This study highlights that a once-daily single-pill antiretroviral regimen can lead to successful virologic suppression among homeless or marginally housed individuals. Presumably, patients who ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UCSF has found. The strategy could also help stop the spread of HIV ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UC San Francisco has found. The strategy could also help stop the spread ...